“The current use of peptides is everything you can think of. From antimicrobial, antioxidant, and anti-obesity uses, to hormone regulation, dyslipidemia, digestion, and cognitive performance enhancement. Virtually every bodily function you can think of utilizes peptides.” – James LaValle, RPh, CCN, MT, DHM, DHPh, A4M Scientific Planning Committee and IPS Steering Committee Chair
The mapping of the human longevity blueprint has launched a new era of research into peptide therapies for precision life extension. Groundbreaking peptide advances welcome a coming age in which the root causes of aging may be targeted, optimized, and potentially reversed – expanding the boundaries of the human lifespan. This paradigm shift represents a transition from reactive to proactive aging management, addressing fundamental age-related decline rather than downstream effects alone.
Today, there are over 90 FDA-approved peptide therapeutics with over 150 in clinical development and up to 600 undergoing preclinical trials. In medical practices across the globe, peptide therapies are being used to help treat cancer, infectious diseases, metabolic disorders, injuries, and much more.
Research continues to unveil the power of peptide therapies for disease management, performance optimization, and longevity strategies.